Investors comparing consumer staples ETFs often face a choice between broad, diversified exposure and a more targeted, small-cap tilt. FXG and PSCC sit at opposite ends of that spectrum even though both live inside the defensive staples sector. FXG, the First Trust Consumer Staples AlphaDEX Fund, applies a rules-based "AlphaDEX" selection model to large- and mid-cap staples stocks, while PSCC, the Invesco S&P SmallCap Consumer Staples ETF, tracks a small-capitalization subset of the S&P SmallCap 600. With food inflation, input-cost pressure, and shifting consumer demand reshaping the staples complex, understanding the structural differences, relative positioning, and risk profiles of these two funds is especially timely. I also checked this using Tickeron’s AI Screener to see how the two compare on key metrics.
FXG seeks to track the StrataQuant Consumer Staples AlphaDEX Index, a modified equal-dollar-weighted benchmark that uses the AlphaDEX methodology to select and weight consumer staples stocks drawn from the Russell 1000 Index. Rather than pure market-cap weighting, the strategy ranks holdings on growth and value factors, giving it a smart-beta tilt. The fund holds roughly 41 names, with a weighted average market capitalization near $40 billion, split between large caps (about 50%) and mid caps (about 46%). Top holdings have historically included Cardinal Health (CAH), Freshpet (FRPT), Pilgrim's Pride (PPC), McCormick (MKC), McKesson (MCK), and Ingredion (INGR). Its expense ratio is 0.63%, and no single position typically exceeds about 5% of assets, keeping concentration low. Launched in May 2007, FXG is a passively managed fund with an enhanced indexing approach.
PSCC seeks to track the S&P SmallCap 600 Capped Consumer Staples Index, a float-adjusted, market-capitalization-weighted benchmark that isolates small-cap U.S. consumer staples companies as defined by the Global Industry Classification Standard (GICS). The fund holds approximately 27 securities and is explicitly non-diversified, meaning a handful of names can drive returns. Top holdings have included Lamb Weston (LW), Conagra Brands (CAG), PriceSmart (PSMT), Cal-Maine Foods (CALM), Freshpet (FRPT), and Vita Coco (COCO), with the largest position sometimes exceeding 10% of assets. Its weighted average market capitalization is roughly $2.9 billion, confirming the small-cap orientation. PSCC carries a low 0.29% expense ratio, uses full replication, and launched in April 2010.
Both funds operate within the consumer staples complex, a defensive sector historically favored during economic uncertainty. Recent market cycles have been shaped by sticky food inflation, volatile agricultural commodity costs, and tariff-related disruptions to supply chains. These dynamics pressure margins for packaged-food producers and distributors, many of which appear in both portfolios. At the same time, GLP-1 weight-loss drugs and shifting snacking preferences are altering long-term volume growth assumptions. Defensive sectors have attracted capital flows during periods of elevated equity-market volatility, supporting staples relative to cyclical areas. Key risks include margin compression from input costs, potential demand weakness from price elasticity, and, for the small-cap segment, reduced pricing power relative to larger branded peers.
In recent weeks and months, the two funds have exhibited different risk-return profiles driven by their capitalization exposure. PSCC's small-cap, non-diversified structure tends to amplify both gains and losses, making its relative positioning more volatile and sensitive to single-stock earnings surprises in names such as Cal-Maine Foods (CALM) and Lamb Weston (LW). FXG, by contrast, blends large- and mid-cap holdings with a factor-driven weighting scheme, which has historically produced lower beta and a steadier defensive profile. Sector rotation into defensive names, combined with interest-rate expectations and earnings cycles among food distributors and protein producers, has favored the broader diversification and larger-cap orientation of FXG, while PSCC remains a higher-conviction, higher-volatility expression of the same theme. From what I see, the liquidity difference also plays a role in execution quality.
When evaluating sector ETFs like these, I often rely on Tickeron’s AI Screener to quickly compare holdings, expense ratios, and risk metrics across similar funds. It helps narrow down options based on capitalization, volatility, and AI-driven signals without manual effort. This approach has been useful for spotting structural differences that matter for longer-term positioning.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
FXG saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 38 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 79%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXG as a result. In 73 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
FXG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.
Following a +1.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 259 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 176 of 272 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows